Inizio Medical’s Post

It’s been an intense few weeks, but the big day is almost here … Nope, we’re not talking about the football … after countless applications, writing tests and conversations, we are incredibly excited to announce that our newest cohort of Associate Medical Writers will start our 𝗮𝗹𝗹𝗲𝗴𝗿𝗼.𝗪𝗥𝗜𝗧𝗘 programme at Inizio Medical on Monday! We cannot wait to welcome everyone to our business – this is the beginning of their individual journeys in med comms and we feel so privileged to be able to guide them through it. See you all at our Macclesfield office soon 🥳 #lifesciences #medcomms #medcommsjobs #medicalwriting

The question isn’t whether ChatGPT will transform Medical Communications. The question is how it will be used to do so. Learn more from Sarah Lochner Meuler, VP Insights Liaison at Inizio Medical in our 2024 AI report: https://lnkd.in/grKmaxEA #HumanPoweredAI #ReimagineHealth #AI #Commercialization #Healthcare

What a fantastic time we had celebrating the final week of our 𝗮𝗹𝗹𝗲𝗴𝗿𝗼.𝗗𝗥𝗜𝗩𝗘 training programme at Inizio Medical! We kicked things off with presentations training, getting the Associate Account Executives on their feet and out of their comfort zones, and finished the week with the cohort reflecting on their time in the programme and sharing key learnings. We are very proud to have witnessed their progress over the past 6 months and look forward to seeing them continue to flourish in their account teams, as they navigate their individual journeys in med comms 🙌 If you are interested in joining a programme to help kick-start your career in Client Services, recruitment for 𝗮𝗹𝗹𝗲𝗴𝗿𝗼.𝗗𝗥𝗜𝗩𝗘 is still open! 𝗮𝗹𝗹𝗲𝗴𝗿𝗼.𝗗𝗥𝗜𝗩𝗘 is part of 𝗮𝗹𝗹𝗲𝗴𝗿𝗼., our award-winning, accelerated learning and development model at Inizio Medical that combines dedicated, expert training with on-the-job learning to help build your perfect med comms career. Visit our website for more information (inizio.health/allegro) and apply to 𝗮𝗹𝗹𝗲𝗴𝗿𝗼.𝗗𝗥𝗜𝗩𝗘 now: https://lnkd.in/eyyx7uvS #lifesciences #medcomms #medcommsjobs #accountexecutive

Several studies presented at the 2024 ASCO® Annual Meeting provided further evidence that circulating tumor DNA (ctDNA) can support early detection and treatment of cancer. Read more about it in our latest blog written by Nancy Sladicka, PhD, Chief Client Officer, Inizio Medical. 👉 https://lnkd.in/eZ96q8wN #ASCO24 #Oncology #ReimagineHealth #Biopharma #Healthcare